Modulation of the Tumor Microenvironment for Cancer Treatment: a Biomaterials Approach

Overview

Journal J Funct Biomater

Specialty Biomedical Engineering

Date 2015 Feb 20

PMID 25695337

Citations 34

Authors

Isaac M Adjei

Sharma Blanka

Affiliations

Soon will be listed here.

Abstract

Tumors are complex tissues that consist of stromal cells, such as fibroblasts, immune cells and mesenchymal stem cells, as well as non-cellular components, in addition to neoplastic cells. Increasingly, there is evidence to suggest that these non-neoplastic cell components support cancer initiation, progression and metastasis and that their ablation or reprogramming can inhibit tumor growth. Our understanding of the activities of different parts of the tumor stroma in advancing cancer has been improved by the use of scaffold and matrix-based 3D systems originally developed for regenerative medicine. Additionally, drug delivery systems made from synthetic and natural biomaterials deliver drugs to kill stromal cells or reprogram the microenvironment for tumor inhibition. In this article, we review the impact of 3D tumor models in increasing our understanding of tumorigenesis. We also discuss how different drug delivery systems aid in the reprogramming of tumor stroma for cancer treatment.

Citing Articles

Functional biomaterials for biomimetic 3D in vitro tumor microenvironment modeling.

Ahmed T In Vitro Model. 2025; 2(1-2):1-23.

PMID: 39872875 PMC: 11756483. DOI: 10.1007/s44164-023-00043-2.

Gene therapy in glioblastoma multiforme: Can it be a role changer?.

Rayati M, Mansouri V, Ahmadbeigi N Heliyon. 2024; 10(5):e27087.

PMID: 38439834 PMC: 10909773. DOI: 10.1016/j.heliyon.2024.e27087.

The Modulatory Effects of Fatty Acids on Cancer Progression.

Westheim A, Stoffels L, Dubois L, van Bergenhenegouwen J, van Helvoort A, Langen R Biomedicines. 2023; 11(2).

PMID: 36830818 PMC: 9953116. DOI: 10.3390/biomedicines11020280.

Signaling pathways in the regulation of cancer stem cells and associated targeted therapy.

Manni W, Min W MedComm (2020). 2022; 3(4):e176.

PMID: 36226253 PMC: 9534377. DOI: 10.1002/mco2.176.

Biopolymer Nanoparticles for Nose-to-Brain Drug Delivery: A New Promising Approach for the Treatment of Neurological Diseases.

Montegiove N, Calzoni E, Emiliani C, Cesaretti A J Funct Biomater. 2022; 13(3).

PMID: 36135560 PMC: 9504125. DOI: 10.3390/jfb13030125.

References

Levental K, Yu H, Kass L, Lakins J, Egeblad M, Erler J . Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009; 139(5):891-906. PMC: 2788004. DOI: 10.1016/j.cell.2009.10.027. View

Tassone E, Valacca C, Mignatti P . Membrane-Type 1 Matrix Metalloproteinase Downregulates Fibroblast Growth Factor-2 Binding to the Cell Surface and Intracellular Signaling. J Cell Physiol. 2014; 230(2):366-77. PMC: 4281515. DOI: 10.1002/jcp.24717. View

Stuckey D, Shah K . Stem cell-based therapies for cancer treatment: separating hope from hype. Nat Rev Cancer. 2014; 14(10):683-91. PMC: 4234304. DOI: 10.1038/nrc3798. View

Feng P, Yu C, Wu C, Lee M, Lee W, Wang L . Tumor-associated macrophages in stage IIIA pN2 non-small cell lung cancer after neoadjuvant chemotherapy and surgery. Am J Transl Res. 2014; 6(5):593-603. PMC: 4212933. View

Nakasone E, Askautrud H, Kees T, Park J, Plaks V, Ewald A . Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance. Cancer Cell. 2012; 21(4):488-503. PMC: 3332002. DOI: 10.1016/j.ccr.2012.02.017. View

Caillou B, Talbot M, Weyemi U, Pioche-Durieu C, Al Ghuzlan A, Bidart J . Tumor-associated macrophages (TAMs) form an interconnected cellular supportive network in anaplastic thyroid carcinoma. PLoS One. 2011; 6(7):e22567. PMC: 3141071. DOI: 10.1371/journal.pone.0022567. View

Auffinger B, Morshed R, Tobias A, Cheng Y, Ahmed A, Lesniak M . Drug-loaded nanoparticle systems and adult stem cells: a potential marriage for the treatment of malignant glioma?. Oncotarget. 2013; 4(3):378-96. PMC: 3717302. DOI: 10.18632/oncotarget.937. View

Hammes L, Tekmal R, Naud P, Edelweiss M, Kirma N, Valente P . Macrophages, inflammation and risk of cervical intraepithelial neoplasia (CIN) progression--clinicopathological correlation. Gynecol Oncol. 2007; 105(1):157-65. DOI: 10.1016/j.ygyno.2006.11.023. View

Porsch H, Mehic M, Olofsson B, Heldin P, Heldin C . Platelet-derived growth factor β-receptor, transforming growth factor β type I receptor, and CD44 protein modulate each other's signaling and stability. J Biol Chem. 2014; 289(28):19747-57. PMC: 4094084. DOI: 10.1074/jbc.M114.547273. View

10.

Sharma B, Peetla C, Adjei I, Labhasetwar V . Selective biophysical interactions of surface modified nanoparticles with cancer cell lipids improve tumor targeting and gene therapy. Cancer Lett. 2013; 334(2):228-36. PMC: 3669664. DOI: 10.1016/j.canlet.2013.03.011. View

11.

Hall B, Dembinski J, Sasser A, Studeny M, Andreeff M, Marini F . Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles. Int J Hematol. 2007; 86(1):8-16. DOI: 10.1532/IJH97.06230. View

12.

Ingber D . Can cancer be reversed by engineering the tumor microenvironment?. Semin Cancer Biol. 2008; 18(5):356-64. PMC: 2570051. DOI: 10.1016/j.semcancer.2008.03.016. View

13.

Khakoo A, Pati S, Anderson S, Reid W, Elshal M, Rovira I . Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med. 2006; 203(5):1235-47. PMC: 2121206. DOI: 10.1084/jem.20051921. View

14.

Sugahara K, Teesalu T, Karmali P, Kotamraju V, Agemy L, Greenwald D . Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs. Science. 2010; 328(5981):1031-5. PMC: 2881692. DOI: 10.1126/science.1183057. View

15.

Bergfeld S, DeClerck Y . Bone marrow-derived mesenchymal stem cells and the tumor microenvironment. Cancer Metastasis Rev. 2010; 29(2):249-61. DOI: 10.1007/s10555-010-9222-7. View

16.

Fang J, Nakamura H, Maeda H . The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev. 2010; 63(3):136-51. DOI: 10.1016/j.addr.2010.04.009. View

17.

Carmeliet P, Jain R . Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov. 2011; 10(6):417-27. DOI: 10.1038/nrd3455. View

18.

Langley R, Fidler I . The seed and soil hypothesis revisited--the role of tumor-stroma interactions in metastasis to different organs. Int J Cancer. 2011; 128(11):2527-35. PMC: 3075088. DOI: 10.1002/ijc.26031. View

19.

Klopp A, Gupta A, Spaeth E, Andreeff M, Marini 3rd F . Concise review: Dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth?. Stem Cells. 2011; 29(1):11-9. PMC: 3059412. DOI: 10.1002/stem.559. View

20.

Wang X, Sun L, Maffini M, Soto A, Sonnenschein C, Kaplan D . A complex 3D human tissue culture system based on mammary stromal cells and silk scaffolds for modeling breast morphogenesis and function. Biomaterials. 2010; 31(14):3920-9. PMC: 2847607. DOI: 10.1016/j.biomaterials.2010.01.118. View